We've been talking about it for months.
And now we're just six days away.
Canada has legalized recreational marijuana nationwide, and that law goes into effect Oct. 17 - exactly six days from today.
That means any adult over 18 will be able to just walk into a dispensary and buy up to 30 grams of cannabis. That could be flower, oils, or - in some places - seeds and plants.
And that could make you a multimillionaire by this time next year.
But only if you act now.
Now, there are a few hiccups here - as expected.
There aren't as many dispensaries as we'd like.
Ontario and Nunavut - Canada's most and least populated provinces, respectively - will have no stores open Oct. 17. British Columbia has one store for its 4.8 million residents, and the Northwest Territories will be home to just six government-run stores - about one per 7,420 residents.
But in the age of online shopping, that's not really a concern.
While the start to legal cannabis may be a little slower than expected, it won't stay slow for long. Manitoba has set a goal to have 90% of residents live within 30 minutes of a dispensary. Ontario is working on opening as many as 40 stores. Already, hundreds of companies have applied to be retailers.
So what's the reason for the slowdown, if everyone seems to be excited about legalization?
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
For one thing, each province has its own set of rules. And many cities and counties in those provinces have their own sets of rules as well.
Plus, in June, Ontario decided that cannabis stores should be privately owned. That was a smart move - but it did reset the time line some.
Online sales are expected to open huge and surge from there. Retailers are expected to spread like, well, weeds in the biggest cities.
We're talking a country of 37 million people. And a market that - when you add in the growers, the value-added product makers, the testing labs, security, tourism, exports, and all the rest - could soon reach $22.6 billion, according to Deloitte.
No wonder multinational beverage, tobacco, and pharmaceutical businesses are now partnering with, or investing in, Canadian cannabis companies.
As legal cannabis in Canada arrives in just six days, they all should see a significant increase in revenue.
So adding the best Canadian pot stocks to a portfolio makes sense - now, before legalization hits.
That's why, in this special presentation, I show pot stock enthusiasts how to get what I think are the best Canadian pot stocks - and only the best Canadian pot stocks.
With the right plays, by this time next year, they could be sitting on $2 million. That's more than enough to pay off a mortgage, take the grandkids to Disney World, or put a down payment on a new car.
So I urge you to watch this short presentation before Oct. 17.
That's just six days away.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.